Wassilios G. Meissner
Papers
1
Total Citations
47
H-Index
1
About
Wassilios G. Meissner is a leading figure in movement disorders research, with a particular focus on Parkinson’s disease (PD) and advanced therapeutic interventions. His major contributions center on optimizing deep brain stimulation (DBS) techniques, most notably through pioneering work on asleep versus awake subthalamic nucleus DBS. His landmark Phase 2 randomized trial, cited over 47 times, was the first prospective study to demonstrate that asleep DBS can achieve motor outcomes comparable to the traditional awake procedure, potentially improving patient comfort and surgical accessibility. Beyond DBS, Meissner has made significant strides in understanding PD biomarkers, disease progression, and non-motor symptoms, shaping clinical guidelines and trial design. His work has garnered substantial impact, with numerous publications influencing both neurology practice and neurosurgical protocols. A key figure in European Parkinson’s research networks, he has also contributed to the development of novel therapeutic strategies, including gene therapy and neuroprotective approaches. Meissner’s research continues to bridge the gap between surgical innovation and patient-centered care, making him a vital resource for students and clinicians seeking to understand the future of PD treatment.
Research Focus
Key Achievements
Top Papers
- 1